Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL GENOTYPING FOR AGRICULTURAL BIOTECHNOLOGY MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 ARRIVING AT THE GLOBAL GENOTYPING FOR AGRICULTURAL BIOTECHNOLOGY MARKET
2.3 VENDOR POSITIONING GRID
2.4 TECHNOLOGY LIFE LINE CURVE
2.5 MARKET GUIDE
2.6 COMPANY POSITIONING GRID
2.7 COMAPANY MARKET SHARE ANALYSIS
2.8 MULTIVARIATE MODELLING
2.9 DEMAND AND SUPPLY-SIDE VARIABLES
2.1 CONSUMPTION TREND OF END PRODUCTS
2.11 TOP TO BOTTOM ANALYSIS
2.12 STANDARDS OF MEASUREMENT
2.13 VENDOR SHARE ANALYSIS
2.14 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.15 DATA POINTS FROM KEY SECONDARY DATABASES
2.16 GLOBAL GENOTYPING FOR AGRICULTURAL BIOTECHNOLOGY MARKET : RESEARCH SNAPSHOT
2.17 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 SUPPLY CHAIN ANALYSIS
5.2 PESTEL ANALYSIS
5.3 GROWING STRATEGIES ADOPTED BY MARKET PLAYERS
5.4 INDUSTRY TRENDS AND FUTURE PRESPECTIVE
5.5 NEW PRODUCT LAUNCHES
5.6 TECHNOLOGICAL INNOVATION IN INDUSTRY
6 REGULATORY FRAMEWORK AND GUIDELINES
7 POST COVID IMPACT ANALYSIS
8 GLOBAL GENOTYPING FOR AGRICULTURAL BIOTECHNOLOGY MARKET, BY TYPE, 2020-2029, (USD MILLION)
8.1 OVERVIEW
8.2 MOLECULAR DIAGNOSTICS
8.3 MOLECULAR MARKERS
8.4 TISSUE CULTURE
8.5 VACCINES
8.6 GENETIC ENGINEERING
8.7 PLANT BREEDING
8.8 OTHERS
9 GLOBAL GENOTYPING FOR AGRICULTURAL BIOTECHNOLOGY MARKET, BY PRODUCT, 2020-2029, (USD MILLION)
9.1 OVERVIEW
9.2 CROP PROTECTION PRODUCTS
9.2.1 BIOSTIMULANTS
9.2.2 BIOPESTICIDES
9.3 TRANSGENIC SEEDS
9.3.1 SOYBEAN
9.3.2 FRUITS & VEGETABLES
9.3.3 MAIZE
9.3.4 COTTON
9.3.5 OTHERS.
9.4 SYNTHETIC BIOLOGY-ENABLES PRODUCTS
10 GLOBAL GENOTYPING FOR AGRICULTURAL BIOTECHNOLOGY MARKET, BY ORGANISM TYPE, 2020-2029, (USD MILLION)
10.1 OVERVIEW
10.2 PLANTS
10.3 ANIMALS
10.4 MICROBES
10.5 OTHERS
11 GLOBAL GENOTYPING FOR AGRICULTURAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020-2029, (USD MILLION)
11.1 OVERVIEW
11.2 TRANSGENIC CROPS
11.3 FLOWER CULTURING
11.4 NUTRITIONAL SUPPLEMENTS
11.5 BIOFUELS
11.6 ANTIBIOTIC DEVELOPMENT
11.7 VACCINE DEVELOPMENT
11.8 OTHERS
12 GLOBAL GENOTYPING FOR AGRICULTURAL BIOTECHNOLOGY MARKET, COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: GLOBAL
12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
12.3 COMPANY SHARE ANALYSIS: EUROPE
12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
12.5 MERGERS & ACQUISITIONS
12.6 NEW PRODUCT DEVELOPMENT & APPROVALS
12.7 EXPANSIONS & PARTNERSHIP
12.8 REGULATORY CHANGES
13 GLOBAL GENOTYPING FOR AGRICULTURAL BIOTECHNOLOGY MARKET, BY GEOGRAPHY, 2020-2029, (USD MILLION)
13.1 GLOBAL GENOTYPING FOR AGRICULTURAL BIOTECHNOLOGY MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
13.2 NORTH AMERICA
13.2.1 U.S.
13.2.2 CANADA
13.2.3 MEXICO
13.3 EUROPE
13.3.1 GERMANY
13.3.2 U.K.
13.3.3 ITALY
13.3.4 FRANCE
13.3.5 SPAIN
13.3.6 RUSSIA
13.3.7 SWITZERLAND
13.3.8 TURKEY
13.3.9 BELGIUM
13.3.10 NETHERLANDS
13.3.11 DENMARK
13.3.12 SWEDEN
13.3.13 POLAND
13.3.14 NORWAY
13.3.15 FINLAND
13.3.16 REST OF EUROPE
13.4 ASIA-PACIFIC
13.4.1 JAPAN
13.4.2 CHINA
13.4.3 SOUTH KOREA
13.4.4 INDIA
13.4.5 SINGAPORE
13.4.6 THAILAND
13.4.7 INDONESIA
13.4.8 MALAYSIA
13.4.9 PHILIPPINES
13.4.10 AUSTRALIA
13.4.11 NEW ZEALAND
13.4.12 VIETNAM
13.4.13 TAIWAN
13.4.14 REST OF ASIA-PACIFIC
13.5 SOUTH AMERICA
13.5.1 BRAZIL
13.5.2 ARGENTINA
13.5.3 REST OF SOUTH AMERICA
13.6 MIDDLE EAST AND AFRICA
13.6.1 SOUTH AFRICA
13.6.2 EGYPT
13.6.3 SAUDI ARABIA
13.6.4 UNITED ARAB EMIRATES
13.6.5 ISRAEL
13.6.6 BAHRAIN
13.6.7 KUWAIT
13.6.8 OMAN
13.6.9 QATAR
13.6.10 REST OF MIDDLE EAST AND AFRICA
14 GLOBAL GENOTYPING FOR AGRICULTURAL BIOTECHNOLOGY MARKET SWOT AND DBMR ANALYSIS
15 GLOBAL GENOTYPING FOR AGRICULTURAL BIOTECHNOLOGY MARKET , COMPANY PROFILE
15.1 KWS SAAT
15.1.1 COMPANY OVERVIEW
15.1.2 REVENUE ANALYSIS
15.1.3 PRODUCT PORTFOLIO
15.1.4 GEOGRAPHIC PRESENCE
15.1.5 RECENT DEVELOPMENTS
15.2 THERMO FISHER SCIENTIFIC
15.2.1 COMPANY OVERVIEW
15.2.2 REVENUE ANALYSIS
15.2.3 PRODUCT PORTFOLIO
15.2.4 GEOGRAPHIC PRESENCE
15.2.5 RECENT DEVELOPMENTS
15.3 BAYER AG
15.3.1 COMPANY OVERVIEW
15.3.2 REVENUE ANALYSIS
15.3.3 PRODUCT PORTFOLIO
15.3.4 GEOGRAPHIC PRESENCE
15.3.5 RECENT DEVELOPMENTS
15.4 INTERTEK GROUP PLC
15.4.1 COMPANY OVERVIEW
15.4.2 REVENUE ANALYSIS
15.4.3 PRODUCT PORTFOLIO
15.4.4 GEOGRAPHIC PRESENCE
15.4.5 RECENT DEVELOPMENTS
15.5 UPL
15.5.1 COMPANY OVERVIEW
15.5.2 REVENUE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 GEOGRAPHIC PRESENCE
15.5.5 RECENT DEVELOPMENTS
15.6 ILLUMINA, INC.
15.6.1 COMPANY OVERVIEW
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 GEOGRAPHIC PRESENCE
15.6.5 RECENT DEVELOPMENTS
15.7 AGILENT TECHNOLOGIES, INC.
15.7.1 COMPANY OVERVIEW
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 GEOGRAPHIC PRESENCE
15.7.5 RECENT DEVELOPMENTS
15.8 QIAGEN
15.8.1 COMPANY OVERVIEW
15.8.2 REVENUE ANALYSIS
15.8.3 PRODUCT PORTFOLIO
15.8.4 GEOGRAPHIC PRESENCE
15.8.5 RECENT DEVELOPMENTS
15.9 BGI
15.9.1 COMPANY OVERVIEW
15.9.2 REVENUE ANALYSIS
15.9.3 PRODUCT PORTFOLIO
15.9.4 GEOGRAPHIC PRESENCE
15.9.5 RECENT DEVELOPMENTS
15.1 NORTH AMERICAN GENOMICS
15.10.1 COMPANY OVERVIEW
15.10.2 REVENUE ANALYSIS
15.10.3 PRODUCT PORTFOLIO
15.10.4 GEOGRAPHIC PRESENCE
15.10.5 RECENT DEVELOPMENTS
15.11 LGC BIOSEARCH TECHNOLOGIES
15.11.1 COMPANY OVERVIEW
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 GEOGRAPHIC PRESENCE
15.11.5 RECENT DEVELOPMENTS
15.12 EUROFINS GENOMICS
15.12.1 COMPANY OVERVIEW
15.12.2 REVENUE ANALYSIS
15.12.3 PRODUCT PORTFOLIO
15.12.4 GEOGRAPHIC PRESENCE
15.12.5 RECENT DEVELOPMENTS
15.13 INTEGRATED DNA TECHNOLOGIES, INC.
15.13.1 COMPANY OVERVIEW
15.13.2 REVENUE ANALYSIS
15.13.3 PRODUCT PORTFOLIO
15.13.4 GEOGRAPHIC PRESENCE
15.13.5 RECENT DEVELOPMENTS
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
16 CONCLUSION
17 QUESTIONNAIRE
18 RELATED REPORTS
19 ABOUT DATA BRIDGE MARKET RESEARCH
